
Sign up to save your podcasts
Or


Interview with Matthew H. G. Katz, MD, author of Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101
By JAMA Network4.1
77 ratings
Interview with Matthew H. G. Katz, MD, author of Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101

11,172 Listeners

12,919 Listeners

317 Listeners

147 Listeners

498 Listeners

1,305 Listeners

162 Listeners

38 Listeners

21 Listeners

12 Listeners

11 Listeners

10 Listeners

16 Listeners

19 Listeners

5 Listeners

7 Listeners

30 Listeners

9 Listeners

92 Listeners

14 Listeners

5 Listeners

5 Listeners

106 Listeners

18 Listeners

5,522 Listeners

3 Listeners